CEO Message

Connecting people and technology to bring new treatment options to patients.

At iXgene, we combine two innovative technologies—induced pluripotent stem (iPS) cells and genome editing—to create new options for patients whose treatment needs remain unmet. We aim to expand therapeutic possibilities by equipping cells with new functions, going beyond restoring lost function. Our mission is to turn discoveries from academic research into medical treatments.

For more than 20 years, I have worked to bring biotechnology into practical use through roles in startups, venture capital, and established companies. These experiences have taught me that turning outstanding science into treatments that reach patients requires not only the passion of researchers, but also the ability to bring together expertise in clinical medicine, business development, manufacturing, and other fields.

New value emerges when people connect and share knowledge across the boundaries of laboratories and companies. At iXgene, we value collaboration with research institutions, medical institutions, companies, and everyone who shares our aspirations. Together, we will address challenges that no single organization can overcome alone.

Developing a new treatment is only part of the journey. It must also be made available in a form that patients who need it can access. Together with our partners, we seek ways to realize the potential of advanced medicine while making it more widely available, paying close attention to manufacturing technologies and how treatments are supplied.

“Today is the youngest I will ever be.” Guided by these words, I will continue to take on new challenges, working to connect the possibilities of science with a better future for patients. Thank you for your understanding and continued support of iXgene.